GlassScriptPhysician profile
Rolf Ehlers
NPI 1205939832
$8,015.01
in general payments reported to CMS, 2019-2025
56 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $605 · 2021: $1,340 · 2022: $1,350 · 2023: $953 · 2024: $1,200 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,539.35 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $917.24 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Abbvie INC. | $801.63 | 2019-2025 | |
| Novo Nordisk INC | $768.39 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $733.38 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $559.95 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $468.58 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbott Laboratories | $322.19 | 2019-2025 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $218.38 | 2019-2025 | |
| Astellas Pharma US INC | $194.29 | 2019-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $182.40 | 2019-2025 | |
| Allergan, INC. | $175.58 | 2019-2021 | |
| Boston Scientific Corporation | $171.43 | 2022-2025 | Wavewriter Alpha Prime 16, Watchman |
| Janssen Pharmaceuticals, INC | $165.52 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.24 | 2020-2024 | Jardiance, Tradjenta, Synjardy |
| Otsuka America Pharmaceutical, INC. | $152.42 | 2021-2025 | Rexulti |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolf Ehlers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.